MEDcounselor Drug Information Now Available on ISMP’s ConsumerMedSafety.org
MEDcounselor’s Drug Information, Drug IDentifier and Drug Interactions Modules Help Consumers Take Medications Safely, Avoid Errors
Tampa, FL – July 20, 2010 – Gold Standard/Elsevier, developer of drug information and medication management solutions, announced today that the Institute for Safe Medication Practices (ISMP) has licensed MEDcounselor Drug Information, Drug IDentifer and Drug Interaction modules for its consumer website, ConsumerMedSafety.org. ISMP is a federally certified patient safety organization that focuses on preventing medication errors and adverse drug events, and offers legal protection and confidentiality for submitted patient safety and error reports.
“As the nation’s only not-for-profit organization of physicians, nurses and pharmacists dedicated exclusively to safe medication practices, ISMP views Gold Standard’s MEDcounselor modules as a valuable tool for empowering consumers to make informed medication decisions and becoming more engaged in their care,” said Michael R. Cohen, RPh, MS, ScD, FASHP, ISMP’s President. “Educating consumers via MEDcounselor supports ISMP in its quest to prevent costly medication errors and advance patient safety worldwide.”
MEDcounselor modules now available via ConsumerMedSafety.org include:
- Drug Information: By typing in the first three letters of a drug’s name, consumers can access medication information (such as uses, interactions and side effects) for every commonly prescribed U.S. prescription drug (e.g., Lipitor, Lexapro), plus herbals, vitamins, nutritional and over-the-counter (OTC) products. Written to comply with all national standards for Consumer Medication Information (CMI), the content is available in both English and Spanish.
- Drug IDentifier: If tablets or capsules get separated from their original packaging, consumers can quickly identify them by entering the marking/imprint, which typically appears in the form of letters or numbers, and/or selecting from among close to 30 colors (e.g., red orange, blue) and 25 shapes (e.g., apple, bow-tie).
- Drug Interactions: Consumers can access information related to potential interactions between prescription, OTC, herbal and nutritional products, as well as caffeine, food, tobacco and alcohol. Interaction alerts include color-coded severity rankings for improved user clarity.
“Gold Standard/Elsevier supports ISMP in its mission to educate the healthcare community and consumers on safe medication practices,” said Marianne Messer, President of Gold Standard. “By accessing MEDcounselor modules on ConsumerMedSafety.org, consumers will get the vital information they need to take drugs safely, identify unknown tablets and capsules, comply with drug regimens and avoid serious medication errors.”
Gold Standard licenses its MEDcounselor modules to pharmacies, consumer health information websites, online communities, health systems and managed care organizations. A specially created “Toolkit” allows organizations to integrate MEDcounselor modules with their existing healthcare content and add search functions and links to drug information from their own Web sites or applications.
“ISMP is truly in the vanguard, offering accessible resources to healthcare consumers who now, more than ever, demand speedy, accurate answers to their medication questions,” said Gold Standard’s Messer. “By partnering with ISMP and ConsumerMedSafety.org, Gold Standard has helped enhance a trusted online resource that millions of healthcare consumers use, value and revisit for life-saving medication insights.”
For more information on MEDcounselor modules, please call 866-417-9150 or email firstname.lastname@example.org. For more information on how consumers can help prevent medication errors and take their medications safely, visit www.ConsumerMedSafety.org.
# # #
About Gold Standard/Elsevier
Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/Elsevier solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Gold Standard/Elsevier, visit www.goldstandard.com.
About the Institute for Safe Medication Practices
The Institute for Safe Medication Practices (ISMP) is an independent, nonprofit charitable organization that works closely with healthcare practitioners and institutions, regulatory agencies, consumers, and professional organizations to provide education about medication errors and their prevention. ISMP represents more than 35 years of experience in helping healthcare practitioners keep patients safe, and continues to lead efforts to improve the medication use process. ISMP is a federally certified patient safety organization (PSO), providing healthcare practitioners and organizations with the highest level of legal protection and confidentiality for patient safety data and error reports they submit to the Institute. For more information on ISMP, or its medication safety alert newsletters and other tools for healthcare professionals and consumers, visit www.ismp.org.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Vice President of Global Relations, Elsevier
+1 212 462 1912